Patent · US Active

Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene

US9161995B2 · kind B2 · utility

7Cited by
34References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 25, 2012
Grant dateOct 20, 2015
Priority date—
Expiry dateJul 25, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/80
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Nucleases and methods of using these nucleases for alteration of a CFTR gene and generation of cells and animal models.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.